Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™)
Zinman, Bernard, Inzucchi, Silvio E, Lachin, John M, Wanner, Christoph, Ferrari, Roberto, Fitchett, David, Bluhmki, Erich, Hantel, Stefan, Kempthorne-Rawson, Joan, Newman, Jennifer, Johansen, Odd Erik, Woerle, Hans-Juergen, Broedl, Uli C
Published in Cardiovascular diabetology (19.06.2014)
Published in Cardiovascular diabetology (19.06.2014)
Get full text
Journal Article
Characterization of hypoactive sexual desire disorder (HSDD) in men
DeRogatis, Leonard, Rosen, Raymond C, Goldstein, Irwin, Werneburg, Brian, Kempthorne-Rawson, Joan, Sand, Michael
Published in Journal of sexual medicine (01.03.2012)
Published in Journal of sexual medicine (01.03.2012)
Get more information
Journal Article
A Review on Telmisartan: A Novel, Long‐Acting Angiotensin II‐Receptor Antagonist
Wienen, Wolfgang, Entzeroth, Michael, Meel, Jacobus C. A., Stangier, Joachim, Busch, Ulrich, Ebner, Thomas, Schmid, Jochen, Lehmann, Horst, Matzek, Kandace, Kempthorne‐Rawson, Joan, Gladigau, Volker, Hauel, Norbert H.
Published in Cardiovascular drug reviews (01.06.2000)
Published in Cardiovascular drug reviews (01.06.2000)
Get full text
Journal Article
Dose response and safety of telmisartan in patients with mild to moderate hypertension
Smith, D H, Matzek, K M, Kempthorne-Rawson, J
Published in Journal of clinical pharmacology (01.12.2000)
Published in Journal of clinical pharmacology (01.12.2000)
Get more information
Journal Article
Prospective, randomized, open-label, blinded-endpoint (PROBE) designed trials yield the same results as double-blind, placebo-controlled trials with respect to ABPM measurements
Smith, David H, Neutel, Joel M, Lacourcière, Yves, Kempthorne-Rawson, Joan
Published in Journal of hypertension (01.07.2003)
Published in Journal of hypertension (01.07.2003)
Get more information
Journal Article